“Loop” domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c …

G Fang, BS Chang, CN Kim, C Perkins, CB Thompson… - Cancer research, 1998 - AACR
G Fang, BS Chang, CN Kim, C Perkins, CB Thompson, KN Bhalla
Cancer research, 1998AACR
Abstract Taxol, 1-β-d-arabinofuranosylcytosine (ara-C), and etoposide induce apoptosis in
HL-60 cells that is blocked by overexpression of Bcl-2 or Bcl-xl. A∼ 60-amino acid “loop”
domain of Bcl-2 and Bcl-xl that contains phosphorylation sites is known to negatively
regulate their antiapoptotic function. In the present studies, Taxol-, ara-C-, or etoposide-
induced apoptosis was examined in HL-60/Bcl-2Δ and HL-60/Bcl-xlΔ cells that express the
loop-deletional mutant cDNA constructs p19Bcl-2Δ32-80 and p18Bcl-xlΔ26–83 …
Abstract
Taxol, 1-β-d-arabinofuranosylcytosine (ara-C), and etoposide induce apoptosis in HL-60 cells that is blocked by overexpression of Bcl-2 or Bcl-xl. A ∼60-amino acid “loop” domain of Bcl-2 and Bcl-xl that contains phosphorylation sites is known to negatively regulate their antiapoptotic function. In the present studies, Taxol-, ara-C-, or etoposide-induced apoptosis was examined in HL-60/Bcl-2Δ and HL-60/Bcl-xlΔ cells that express the loop-deletional mutant cDNA constructs p19Bcl-2Δ32-80 and p18Bcl-xlΔ26–83, respectively. This was compared with control HL-60/neo cells as well as HL-60/Bcl-2 and HL-60/Bcl-xl cells. The latter two cell lines overexpress full-length Bcl-2 and Bcl-xl, respectively. Immunoblot analyses showed that HL-60/neo and HL-60/Bcl-2Δ cells express similar levels of p26Bcl-2. In contrast, as compared with HL-60/neo, HL-60/Bcl-xlΔ cells expressed significantly lower levels of p26Bcl-2. p29Bcl-xl and p21Bax levels were similar in all cell types. Exposure to etoposide (50 µm) or ara-C (100 µm) for 4 h induced apoptosis in HL-60/neo cells, but not in HL-60/Bcl-2, HL-60/Bcl-xl, HL-60/Bcl-2Δ, or HL-60/Bcl-xlΔ cells. In contrast, Taxol treatment (500 nm for 24 h) triggered the molecular cascade of apoptosis, represented by the cytosolic increase of cytochrome c and poly(ADP-ribose) polymerase or the DNA fragmentation factor cleavage activity of caspase-3 in HL-60/neo cells as well as in HL-60/Bcl-xlΔ and HL-60/Bcl-2Δ cells, but not in their counterparts overexpressing full-length Bcl-2 and Bcl-xl. Equal amounts of p26Bcl-2 were coimmunoprecipitated with apoptosis protease-activating factor 1 (APAF-1) in HL-60/neo and HL-60/Bcl-2Δ cells, whereas a markedly higher level of p26Bcl-2 coimmunoprecipitated with APAF-1 in HL-60/Bcl-2 cells. In association with Taxol-induced apoptosis, the levels of Bcl-2 that were coimmunoprecipitated with APAF-1 declined in HL-60/neo and HL-60/Bcl-2Δ cells. This was not observed in HL-60/Bcl-2 cells, in which Taxol-induced apoptosis was blocked. Previous studies have demonstrated that Taxol induces phosphorylation of Bcl-2 in association with Taxol-induced apoptosis of HL-60/neo cells. Immunoblot analysis demonstrated a Taxol-induced mobility shift of Bcl-2 but not p19Bcl-2Δ. Taxol also increased [32P]Pi incorporation in p26Bcl-2, but not in p19Bcl-2Δ or p18Bcl-xl. These findings indicate that the loop domain is necessary for the Taxol-induced mobility shift and phosphorylation of Bcl-2. Loop domain also seems to be necessary for the antiapoptotic effect of Bcl-2 against Taxol-induced apoptosis but not ara-C- or etoposide-induced apoptosis.
AACR